Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease

NCT02533349 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Laryngopharyngeal Reflux Disease

Interventions

DRUG: Motilitone
DRUG: Pantoprazole
DRUG: Placebo

Sponsor

Samsung Medical Center